SAN DIEGO (Reuters) – Nearly 40 percent of lymphoma patients treated with a single infusion of Gilead Sciences Inc’s Yescarta were still responding to the cell therapy after at least two years of follow-up, the company said on Sunday. FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1,… Read More: High-cost Gilead cell therapy proves durable for some lymphoma patients »
Many of the medical truths we hold to be self-evident are actually assumptions. Our 5-Star selections this week are good examples. Many of us assume medical devices are rigorously tested before going to market. That bed rest keeps premature labor at bay. Or, that electronic medical records (EMRs) will make health care delivery more streamlined… Read More: 5-Star Friday: Assumptions »
— First things first. I can see how many of you off the spectrum, those referred to as neurotypicals, could read the headline as saying that people off the spectrum don’t understand people on the spectrum.That’s NOT what I’m saying at all. I’m saying it’s true that many on the spectrum aren’t understood by those… Read More: The Autistic Week That Was »
Homeopathy has been a form of medicine for hundreds of years. Dana Ullman, whose father was a medical doctor, a pediatrician and allergist, has dedicated a significant portion of his professional life to the practice of homeopathy. Ullman was introduced to this medical art as a junior at University of California (UC) Berkeley, in 1973.… Read More: Evidence-Based Homeopathic Family Medicine »